Stockreport

Tarsus Pharmaceuticals Inc. Announces Pricing of Initial Public Offering

Tarsus Pharmaceuticals, Inc.  (TARS) 
PDF IRVINE, Calif., Oct. 15, 2020 (GLOBE NEWSWIRE) -- Tarsus Pharmaceuticals, Inc., (“Tarsus”) a late clinical-stage biopharmaceutical company focused on the development a [Read more]